Pharmacokinetics, Safety and Tolerability of HPP737, a Novel PDE4 Inhibitor, in Healthy Chinese Participants: Phase I Study.

HPP737 - vTv Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42199814

Fei Wang; Lijun Ye; Lin Wang; Nengming Lin; Qian Zhu; Qinghua Zhu; Shufan Cai; XueXia Tao; Yuannian Li

May 28, 2026